You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: November 22, 2024

ATRIDOX Drug Patent Profile


✉ Email this page to a colleague

« Back to Dashboard


Which patents cover Atridox, and when can generic versions of Atridox launch?

Atridox is a drug marketed by Den-mat and is included in one NDA.

The generic ingredient in ATRIDOX is doxycycline hyclate. There are twenty-eight drug master file entries for this compound. Seventy-four suppliers are listed for this compound. Additional details are available on the doxycycline hyclate profile page.

DrugPatentWatch® Litigation and Generic Entry Outlook for Atridox

A generic version of ATRIDOX was approved as doxycycline hyclate by CARIBE HOLDINGS on November 8th, 1982.

  Sign Up

AI Research Assistant
Questions you can ask:
  • What is the 5 year forecast for ATRIDOX?
  • What are the global sales for ATRIDOX?
  • What is Average Wholesale Price for ATRIDOX?
Summary for ATRIDOX
US Patents:0
Applicants:1
NDAs:1
Raw Ingredient (Bulk) Api Vendors: 55
Clinical Trials: 2
Patent Applications: 438
What excipients (inactive ingredients) are in ATRIDOX?ATRIDOX excipients list
DailyMed Link:ATRIDOX at DailyMed
Drug patent expirations by year for ATRIDOX
Recent Clinical Trials for ATRIDOX

Identify potential brand extensions & 505(b)(2) entrants

SponsorPhase
The Forsyth InstitutePhase 2
National Institute of Dental and Craniofacial Research (NIDCR)Phase 2
Milton S. Hershey Medical CenterN/A

See all ATRIDOX clinical trials

US Patents and Regulatory Information for ATRIDOX

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Den-mat ATRIDOX doxycycline hyclate SYSTEM, EXTENDED RELEASE;PERIODONTAL 050751-001 Sep 3, 1998 DISCN Yes No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.